Douglas M. Sammond

Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: The discovery of GW0385

John F. Miller, C. Webster Andrews, Michael Brieger et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 78 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Spirocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: From Hit to Lowering of Cerebrospinal Fluid (CSF) Amyloid β in a Higher Species

Kevin W. Hunt, Adam W. Cook, Ryan J. Watts et al. · Journal of Medicinal Chemistry · 2013 · 58 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors

Alex G. Waterson, Kimberly G. Petrov, Keith R. Hornberger et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 40 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +12

Discovery of 7-Tetrahydropyran-2-yl Chromans: β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors That Reduce Amyloid β-Protein (Aβ) in the Central Nervous System

Allen A. Thomas, Kevin W. Hunt, Matthew Volgraf et al. · Journal of Medicinal Chemistry · 2014 · 38 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Discovery of a novel and potent series of dianilinopyrimidineurea and urea isostere inhibitors of VEGFR2 tyrosine kinase

Douglas M. Sammond, Kristen E. Nailor, James M. Veal et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 30 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13